ArticleCancers2022

Pre-Existing Interstitial Lung Abnormalities Are Independent Risk Factors for Interstitial Lung Disease during Durvalumab Treatment after Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung Cancer.

Wakako Daido et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.